MOESM1 of Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan

Additional file 1. Scatter plot body weight vs. total dose SP received. red line = target dose recommended by the WHO